Clinical Trial

Hepatoprotective Effects of Reishi Mushroom- (Ganoderma Lucidum) Among Metabolic Dysfunction-associated Fatty Liver Disease Patients

Recruiting
View on ClinicalTrials.gov →
Summary
This 12-week RCT investigates the hepatoprotective and immunomodulatory effects of Ganoderma lucidum combined with a probiotic-rich diet in adults with MAFLD, assessing liver enzymes, lipid profile, inflammation, gut microbiota, and oxidative stress. Findings are expected to show dose-dependent improvements in hepatic fat, insulin resistance, and inflammatory markers, potentially reducing reliance on pharmacotherapy in
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2026-02-01 -> 2025-12-31 2026-07-31
minor Completion pushed: 2026-04-15 -> 2026-12-15 2026-07-31
Trial Details
NCT Number NCT07534241
Lead Sponsor University of Lahore
Conditions Lipid Profile, Liver Biomarkers
Enrollment 102 participants
Start Date 2025-10-02
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-30